Description:

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Recurrent Gynecologic Cancer - On Study Form - FORM OSR Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA533423-E4AA-53B9-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA533423-E4AA-53B9-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 6/26/15
Uploaded on:

June 26, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Recurrent Gynecologic Cancer - On Study Form - FORM OSR

No Instruction available.

  1. StudyEvent: GYNECOLOGIC ONCOLOGY GROUP Recurrent Gynecologic Cancer - On Study Form - FORM OSR
    1. No Instruction available.
Patient demographics
Disease Description - Prior History
Stage (at diagnosis FIGO)
Primary surgery type (check all that apply)
Disease Description - Current History
Current status of disease
What was the method used to determine progression? (recurrence or)
Site(s) of disease (at study entry)
Prior Treatment For Gynecologic Cancer
Prior systemic chemotherapy?
Chemotherapy regimen
Prior hormonal therapy?
Non-protocol biologic response modifier?
Prior radiation therapy?
Is the site of recurrence within the field previously treated by radiation therapy?
Comments

Similar models